Concepedia

David J. Graham

DJ

Statistics

Publications

82

Citations

7.3K

H-Index

37

Active since

1987

Affiliations

United States Food and Drug Administration(Current)

Center for Drug Evaluation and Research

Acumen (United States)

Centers for Medicare and Medicaid Services

Kaiser Permanente

David J. Graham is an author at United States Food and Drug Administration specializing in medicine, cardiovascular disease, and nervous system.

ORCID

Top concepts

Publications per year

1987–2024

82

Publications

82

Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study

David J. Graham, David Campen, Rita L. Hui et al. · The Lancet · 2005 · 909 citations

, , +9

Incidence of Hospitalized Rhabdomyolysis in Patients Treated With Lipid-Lowering Drugs

David J. Graham · JAMA · 2004 · 875 citations

Cardiovascular, Bleeding, and Mortality Risks in Elderly Medicare Patients Treated With Dabigatran or Warfarin for Nonvalvular Atrial Fibrillation

David J. Graham, Marsha E. Reichman, Michael Wernecke et al. · Circulation · 2014 · 640 citations · Full text

Risk of Acute Myocardial Infarction, Stroke, Heart Failure, and Death in Elderly Medicare Patients Treated With Rosiglitazone or Pioglitazone

David J. Graham, Rita Ouellet‐Hellstrom, Thomas MaCurdy et al. · JAMA · 2010 · 504 citations

Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated With Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation

David J. Graham, Marsha E. Reichman, Michael Wernecke et al. · JAMA Internal Medicine · 2016 · 319 citations

1–5 of 82